Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
Alle Spezies anzeigen
Weitere Synonyme anzeigen
Wählen Sie die Spezies und Applikation aus
anti-Mouse (Murine) VAMP2 Antikörper:
anti-Rat (Rattus) VAMP2 Antikörper:
anti-Human VAMP2 Antikörper:
Sie gelangen zu unserer vorgefilterten Suche.
Cow (Bovine) Polyclonal VAMP2 Primary Antibody für FACS, IF - ABIN4364759
Rosado, Redondo, Salido, Sage, Pariente: Cleavage of SNAP-25 and VAMP-2 impairs store-operated Ca2+ entry in mouse pancreatic acinar cells. in American journal of physiology. Cell physiology 2004
Show all 4 Pubmed References
Human Polyclonal VAMP2 Primary Antibody für ICC, IP - ABIN1742194
Kung, Gong, Adedoyin, Ng, Bhargava, Ohara, Jasmin: Evidence for glutamate as a neuroglial transmitter within sensory ganglia. in PLoS ONE 2013
Show all 3 Pubmed References
Human Polyclonal VAMP2 Primary Antibody für ICC, IF - ABIN407569
Kong, Wong, Chan, Lo: Chronic exposure of adult rats to low doses of methylmercury induced a state of metabolic deficit in the somatosensory cortex. in Journal of proteome research 2013
findings reveal a novel signalling pathway involved in development of the semicircular canal system, and suggest a previously unrecognized role for NCS-1 (zeige NCS1 Antikörper) in mitochondrial function via its association with several mitochondrial proteins.
These observations provide evidence that the synaptobrevin-2 transmembrane domain catalyzes the membrane fusion process by its structural flexibility, actively setting the pace of fusion pore expansion.
Syp1 (zeige SYP Antikörper) clears Syb2 from the presynaptic active zone to prevent short-term depression.
The balance between synaptophysin (zeige SYP Antikörper) and sybII levels is critical for the correct targeting of sybII to synaptic vesicles and suggests that alterations in synaptophysin (zeige SYP Antikörper) levels might affect the localisation of sybII and subsequent presynaptic performance.
Thus, lipid-anchored syb2 provides little or no support for exocytosis, and anchoring syb2 to a membrane by a TMD (zeige TTN Antikörper) greatly improves its function
Vamp2 mutations impair the ability of Munc18-1 (zeige STXBP1 Antikörper) to promote trans-SNARE (zeige VTI1B Antikörper) zippering. These mutations inhibit spontaneous as well as evoked neurotransmitter release, providing evidence for the Vamp2-regulating function of Munc18-1 (zeige STXBP1 Antikörper) in synaptic exocytosis.
These results provide a novel molecular mechanism for autocrine negative feedback regulation of insulin (zeige INS Antikörper) secretion.
Results suggest that side chains in the syb2 transmembrane domain influence the kinetics of exocytosis by perturbing the packing of the surrounding lipids
we demonstrate that Syb2 and SNAP25 (zeige SNAP25 Antikörper) mediate the vesicular release of BDNF (zeige BDNF Antikörper) in axons and dendrites of cortical neurons
Here we report on transgenic mice expressing a ubiquitinated synaptic vesicle protein (Ub(G76V)-GFP-Syb2) that develop progressive degeneration of motor nerve terminals.
VAMP2 is the major v-SNARE (zeige GOSR1 Antikörper) involved in GLUT4 (zeige SLC2A4 Antikörper) trafficking to the surface of 3T3-L1 adipocytes.
Data suggest that A-syn (zeige FYN Antikörper) (alpha-synuclein) promotes SNARE (zeige NAPA Antikörper)-dependent vesicle docking; phosphatidylserine (PS) removal from t-SNARE (zeige NAPA Antikörper)-bearing vesicles causes A-syn (zeige FYN Antikörper) to inhibit vesicle docking; PS removal from v-SNARE (zeige VTI1B Antikörper)-bearing vesicles promotes vesicle docking; the C-terminal 45 residues of A-syn (zeige FYN Antikörper) are required for promotion of vesicle docking. (Here, t-SNARE (zeige NAPA Antikörper) is SNAP-25 (zeige SNAP25 Antikörper); v-SNARE (zeige VTI1B Antikörper) is VAMP2.)
A significant interactive two-locus model of STX1A_rs4363087|VAMP2_rs2278637 (presynaptic genes) was observed among SVC (zeige COL4A1 Antikörper) variants in all epilepsy cases.
VAMP2 is a promising new plasma cell marker
VAMP2 is involved in Porphyromonas gingivalis recycling pathway.VAMP2 is localized in early endosomes in gingival epithelial cells.
The present study addressed for the first time the unique substrate recognition mechanism of LC/F5 substrate cleavage of VAMP-2 by Botulinum Neurotoxin subtype F5.
This study showed that decreased Levels of VAMP2 correlate with Duration of Dementia.
VAMP2-NRG1 (zeige NRG1 Antikörper) is a novel oncogenic fusion gene representing a new addition to the list of NRG1 (zeige NRG1 Antikörper) fusion genes, which together may form an important diagnostic and clinical category of lung adenocarcinoma cases
A large vesicular pool of VAMP2 maintained by AP180 (zeige SNAP91 Antikörper) is crucial to sustain efficient neurotransmission.
SNARE (zeige NAPA Antikörper) complex genes and their interactions may play a significant role in susceptibility and working memory of ADHD.
miR (zeige MLXIP Antikörper)-206 regulates lung surfactant secretion by limiting the availability of VAMP-2 protein.
VAMP-2 is critical to lysosome fusion in membrane raft clustering, and this VAMP-2-mediated lysosome-MR signalosomes contribute to redox regulation of coronary endothelial function.
VAMP2 is restricted from forming the SNARE (zeige NAPA Antikörper) (soluble N-ethylmaleimide-sensitive fusion protein (zeige NSF Antikörper) attachment protein receptor) complex in chromaffin granules from adrenal medullae to the same degree as in brain-purified synaptic vesicles.
Lengthening juxtamembrane region of synaptobrevin-2 severely reduced occurrence of rapid single events, leaving slow ones unchanged. It also impaired increase in fast-fusion mode that normally follows elevation of intracellular Ca2 (zeige CA2 Antikörper)+ levels.
The protein encoded by this gene is a member of the vesicle-associated membrane protein (VAMP)/synaptobrevin family. Synaptobrevins/VAMPs, syntaxins, and the 25-kD synaptosomal-associated protein SNAP25 are the main components of a protein complex involved in the docking and/or fusion of synaptic vesicles with the presynaptic membrane. This gene is thought to participate in neurotransmitter release at a step between docking and fusion. The protein forms a stable complex with syntaxin, synaptosomal-associated protein, 25 kD, and synaptotagmin. It also forms a distinct complex with synaptophysin. It is a likely candidate gene for familial infantile myasthenia (FIMG) because of its map location and because it encodes a synaptic vesicle protein of the type that has been implicated in the pathogenesis of FIMG.
vesicle-associated membrane protein 2 (synaptobrevin 2)
, synaptobrevin II
, vesicle-associated membrane 2
, Synaptobrevin 2 (vesicle-associated membrane protein VAMP-2)
, Vesicle-associated membrane protein (synaptobrevin 2)
, synaptobrevin 2
, vesicle associated membrane protein 2
, vesicle-associated membrane protein 2